CellWell record HH-12680
Unveiling Butyrate as a Parkinson's Disease Therapy.
Abreu AE; Empadinhas N; Cardoso SM
Neuroscience bulletin ยท 2026
In plain language
Reduced gut butyrate levels from bacterial dysbiosis are linked to increased intestinal permeability and neuroinflammation, and butyrate supplementation is being explored across gut-first and brain-first models of Parkinson's disease.
- Studied in
- Human, Animal
Cite this record: https://thecellwell.org/studies/HH-12680
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.